David Earl Bogucki

This inventor holds 32 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Chemokine Receptor Binding. Top assignees: Anormed, Inc., Genzyme Corporation, Aquinox Pharmaceuticals (Canada) Inc.. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Earl Bogucki. Retrieved from https://idiyas.com/inventor/david-earl-bogucki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 7)

% Patents Active = 40.6

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 8.5

ph-index = 13

Forward Citations = 325(Granted Patents)

Company Filing History:

Aquinox Pharmaceuticals (Canada) Inc.

patents

4. 1 out of 2

Apogee Pharmaceuticals, Inc.

patents

5. 1 out of 110

Xenon Pharmaceuticals Inc.

patents

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Chemokine Receptor

Heterocyclic Compounds

MAGL Inhibitors

Therapeutic Agents

CXCR4 Antagonists

SHIP1 Modulators

Antiviral Compounds

Binding Efficacy

Small Molecules

Compositions

Medicinal Chemistry

Drug Development

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378231 - Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof (2025-08-05),

2. 11174268 - Benzenesulfonamide compouds and their use as therapeutic agents (2021-11-16),

3. 10322111 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2019-06-18),

4. 10272081 - SHIP1 modulators and methods related thereto (2019-04-30),

5. 10174046 - SHIP1 modulators and methods related thereto (2019-01-08),

6. 10100056 - SHIP1 modulators and methods related thereto (2018-10-16),

7. 9937167 - SHIP1 modulators and methods related thereto (2018-04-10),

8. 9765085 - SHIP1 modulators and methods related thereto (2017-09-19),

9. 9540353 - SHIP1 modulators and methods related thereto (2017-01-10),

10. 8778967 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2014-07-15),

11. 7807694 - Chemokine receptor binding heterocyclic compounds (2010-10-05),

12. 7709486 - CXCR4 antagonists (2010-05-04),

13. 7629337 - Chemokine receptor binding heterocyclic compounds (2009-12-08),

14. 7498346 - Chemokine receptor binding compounds (2009-03-03),

15. 7491735 - Chemokine receptor binding compounds (2009-02-17),

Title: David Earl Bogucki - Pioneering Inventor from Surrey, CA

Introduction: David Earl Bogucki is a renowned inventor hailing from Surrey, Canada, known for his groundbreaking contributions to various technological fields.

Latest Patents: David Bogucki holds several patents in the areas of renewable energy, sustainable agriculture, and advanced robotics, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Bogucki has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, David Earl Bogucki has collaborated with top companies, visionary inventors, and forward-thinking scientists to bring his ideas to life and make a lasting impact on society.

Conclusion: David Earl Bogucki's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.